Robots have been used in surgery since the late
1980s. Orthopaedic surgery began to incorporate robotic technology
in 1992, with the introduction of ROBODOC, for the planning and
performance of total hip replacement. The use of robotic systems
has subsequently increased, with promising short-term radiological
outcomes when compared with traditional orthopaedic procedures.
Robotic systems can be classified into two categories: autonomous
and haptic (or surgeon-guided). Passive surgery systems, which represent
a third type of technology, have also been adopted recently by orthopaedic
surgeons. While autonomous systems have fallen out of favour, tactile systems
with technological improvements have become widely used. Specifically,
the use of tactile and passive robotic systems in unicompartmental
knee replacement (UKR) has addressed some of the historical mechanisms
of failure of non-robotic UKR. These systems assist with increasing
the accuracy of the alignment of the components and produce more
consistent ligament balance. Short-term improvements in clinical
and radiological outcomes have increased the popularity of robot-assisted
UKR. Robot-assisted orthopaedic surgery has the potential for improving
surgical outcomes. We discuss the different types of robotic systems
available for use in orthopaedics and consider the indication, contraindications
and limitations of these technologies.
Caveolae, specialised regions of the cell membrane which have been detected in a wide range of mammalian cells, have not been described in bone cells. They are plasmalemmal invaginations, 50 to 100 nm in size, characterised by the presence of the structural protein, caveolin, which exists as three subtypes. Caveolin-1 and caveolin-2 are expressed in a wide range of cell types whereas caveolin-3 is thought to be a muscle-specific subtype. There is little information on the precise function of caveolae, but it has been proposed that they play an important role in signal transduction. As the principal bone-producing cell, the osteoblast has been widely studied in an effort to understand the signalling pathways by which it responds to extracellular stimuli. Our aim in this study was to identify caveolae and their structural protein caveolin in normal human osteoblasts, and to determine which subtypes of caveolin were present. Confocal microscopy showed staining which was associated with the plasma membrane. Transmission electron microscopy revealed the presence of membrane invaginations of 50 to 100 nm, consistent with the appearance of caveolae. Finally, we isolated protein from these osteoblasts, and performed Western blotting using anti-caveolin primary antibodies. This revealed the presence of caveolin-1 and -2, while caveolin-3 was absent. The identification of these structures and their associated protein may provide a significant contribution to our further understanding of signal transduction pathways in osteoblasts.